|
Post by hawaiiguy42 on Jan 13, 2016 18:59:43 GMT -5
Live Mic Matt... Live Mic... shhhhhh, LOL!
|
|
|
Post by doodyfree on Jan 13, 2016 19:00:12 GMT -5
How much is their valencia building worth? Real estate in LA is hot
|
|
|
Post by bill on Jan 13, 2016 19:00:47 GMT -5
Existing cash expected to last well into 2nd half 2016, but wants and expects to improve on that position before then.
|
|
|
Post by factspls88 on Jan 13, 2016 19:01:29 GMT -5
Cash remains a major uncertainty. I'm concerned.
|
|
|
Post by stevil on Jan 13, 2016 19:03:03 GMT -5
I only heard the bit about inhaled epi? Were any of the others discussed? I kind of hope that we're not pinning our hopes on inhaled epi. While kids are usually the ones that need to carry the pens around with them the most, anaphylaxis usually includes a swollen tongue/throat (would probably occlude the particles from entering lungs) and restricted breathing, making inhalation problematic. Really hoping we don't put too many resources into this one as I don't see it really going anywhere.
|
|
|
Post by bradleysbest on Jan 13, 2016 19:07:45 GMT -5
Cash is a major concern. Hopefully something happens soon in the way of a partnership.
|
|
|
Shoutbox
Jan 13, 2016 19:09:06 GMT -5
via mobile
Post by vestful on Jan 13, 2016 19:09:06 GMT -5
Is the q & a streaming?
|
|
|
Post by hawaiiguy42 on Jan 13, 2016 19:09:59 GMT -5
yes
|
|
|
Post by compound26 on Jan 13, 2016 19:11:56 GMT -5
Raymond W. Urbanski appears to be a very good speaker. He will be able to help Matt a lot going forward.
|
|
|
Post by bthomas55ep on Jan 13, 2016 19:12:02 GMT -5
Cash is a major concern. Hopefully something happens soon in the way of a partnership. My sense is that they are going to keep US distribution and create multiple partnerships for ROW as a way to create cash while they do smaller partnerships for T/S applications to perform the clinical studies.
|
|
|
Post by mindovermatter on Jan 13, 2016 19:13:48 GMT -5
Cash is a major concern. Hopefully something happens soon in the way of a partnership. My sense is that they are going to keep US distribution and create multiple partnerships for ROW as a way to create cash while they do smaller partnerships for T/S applications to perform the clinical studies. Matt said what I have mentioned before. SNY could possibly give MNKD a nice cash good bye present. It's being negotiated. Whether or not they'll get anything remains to be seen but Matt hinted it's being discussed.
|
|
|
Post by hawaiiguy42 on Jan 13, 2016 19:16:47 GMT -5
Glad he is aware and got pounded (calls) about transparency. He must have been severely pounded with calls.
|
|
|
Shoutbox
Jan 13, 2016 19:17:27 GMT -5
via mobile
Post by boytroy88 on Jan 13, 2016 19:17:27 GMT -5
Is the audio going in and out for you guys you?
|
|
|
Post by humann on Jan 13, 2016 19:18:17 GMT -5
How much is their valencia building worth? Real estate in LA is hot He said ~$23M, I believe.
|
|
|
Post by stevil on Jan 13, 2016 19:18:41 GMT -5
Is the audio going in and out for you guys you? it was earlier but it's been constant since the Q&A session started.
|
|